Important: A Big Prediction of Our Senior Analyst
Here is the latest financial fact sheet of HESTER BIOSCIENCES. For more details, see the HESTER BIOSCIENCES quarterly results and HESTER BIOSCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.5 |
No. of shares | m | 8.51 |
1 Week | % | -1.1 |
1 Month | % | -11.4 |
1 Year | % | -21.5 |
52 week H/L | Rs | 1,999.0/1,416.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
HESTER BIOSCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,825 | 2,044 | 2,278 | 3,180 | 2,852 | |
Low | Rs | 1,040 | 870 | 934 | 1,887 | 1,416 | |
Sales per share (Unadj.) | Rs | 209.2 | 215.4 | 251.9 | 276.2 | 312.7 | |
Earnings per share (Unadj.) | Rs | 47.8 | 36.4 | 40.8 | 46.4 | 32.9 | |
Diluted earnings per share | Rs | 47.8 | 36.4 | 40.8 | 46.4 | 33.0 | |
Cash flow per share (Unadj.) | Rs | 61.6 | 51.8 | 56.4 | 65.9 | 57.3 | |
Dividends per share (Unadj.) | Rs | 11.00 | 6.60 | 10.00 | 10.00 | 8.00 | |
Adj. dividends per share | Rs | 11.00 | 6.60 | 10.00 | 10.00 | 8.00 | |
Avg Dividend yield | % | 0.8 | 0.5 | 0.6 | 0.4 | 0.4 | |
Book value per share (Unadj.) | Rs | 208.5 | 236.3 | 268.3 | 305.5 | 328.7 | |
Adj. book value per share | Rs | 208.6 | 236.4 | 268.4 | 305.6 | 328.8 | |
Shares outstanding (eoy) | m | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | |
Price / Sales ratio | x | 6.8 | 6.8 | 6.4 | 9.2 | 6.8 | |
Avg P/E ratio | x | 29.9 | 40.0 | 39.4 | 54.6 | 64.7 | |
P/CF ratio (eoy) | x | 23.2 | 28.1 | 28.5 | 38.4 | 37.3 | |
Price / Book Value ratio | x | 6.9 | 6.2 | 6.0 | 8.3 | 6.5 | |
Dividend payout | % | 23.0 | 18.1 | 24.5 | 21.5 | 24.3 | |
Avg Mkt Cap | Rs m | 12,186 | 12,396 | 13,661 | 21,552 | 18,152 | |
Total wages/salary | Rs m | 289 | 407 | 389 | 453 | 560 |
HESTER BIOSCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,781 | 1,833 | 2,143 | 2,350 | 2,661 | |
Other income | Rs m | 72 | 64 | 47 | 137 | 154 | |
Total revenues | Rs m | 1,853 | 1,896 | 2,190 | 2,487 | 2,814 | |
Gross profit | Rs m | 680 | 554 | 653 | 604 | 548 | |
Depreciation | Rs m | 118 | 131 | 133 | 166 | 207 | |
Interest | Rs m | 66 | 74 | 66 | 41 | 93 | |
Profit before tax | Rs m | 569 | 413 | 501 | 535 | 402 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 162 | 103 | 154 | 140 | 121 | |
Profit after tax | Rs m | 407 | 310 | 347 | 395 | 280 | |
Gross profit margin | % | 38.2 | 30.2 | 30.5 | 25.7 | 20.6 | |
Effective tax rate | % | 28.4 | 25.0 | 30.7 | 26.2 | 30.2 | |
Net profit margin | % | 22.9 | 16.9 | 16.2 | 16.8 | 10.5 |
HESTER BIOSCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,417 | 1,593 | 1,615 | 1,948 | 2,276 | |
Current liabilities | Rs m | 487 | 835 | 614 | 969 | 1,487 | |
Net working cap to sales | % | 52.2 | 41.4 | 46.7 | 41.6 | 29.7 | |
Current ratio | x | 2.9 | 1.9 | 2.6 | 2.0 | 1.5 | |
Inventory Days | Days | 12 | 21 | 13 | 75 | 47 | |
Debtors Days | Days | 67,366,745 | 116 | 84 | 86 | 109 | |
Net fixed assets | Rs m | 1,578 | 2,273 | 2,495 | 3,674 | 4,424 | |
Share capital | Rs m | 85 | 85 | 85 | 85 | 85 | |
"Free" reserves | Rs m | 1,690 | 1,926 | 2,198 | 2,515 | 2,712 | |
Net worth | Rs m | 1,775 | 2,011 | 2,283 | 2,600 | 2,797 | |
Long term debt | Rs m | 584 | 765 | 828 | 1,645 | 1,849 | |
Total assets | Rs m | 2,995 | 3,866 | 4,110 | 5,622 | 6,700 | |
Interest coverage | x | 9.6 | 6.6 | 8.6 | 14.2 | 5.3 | |
Debt to equity ratio | x | 0.3 | 0.4 | 0.4 | 0.6 | 0.7 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | |
Return on assets | % | 15.8 | 9.9 | 10.0 | 7.7 | 5.6 | |
Return on equity | % | 22.9 | 15.4 | 15.2 | 15.2 | 10.0 | |
Return on capital | % | 26.9 | 17.5 | 18.2 | 13.6 | 10.6 | |
Exports to sales | % | 6.7 | 11.0 | 16.6 | 9.8 | 11.6 | |
Imports to sales | % | 2.5 | 0.6 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 120 | 202 | 357 | 230 | 309 | |
Imports (cif) | Rs m | 45 | 12 | 0 | 0 | 0 | |
Fx inflow | Rs m | 128 | 366 | 357 | 230 | 309 | |
Fx outflow | Rs m | 74 | 42 | 21 | 137 | 39 | |
Net fx | Rs m | 54 | 324 | 336 | 93 | 270 |
HESTER BIOSCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 467 | 368 | 581 | 87 | 236 | |
From Investments | Rs m | -217 | -745 | -384 | -1,166 | -770 | |
From Financial Activity | Rs m | 27 | 187 | -182 | 1,115 | 418 | |
Net Cashflow | Rs m | 283 | -171 | -23 | 35 | -116 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: Bhupendra V Gandhi | COMP SEC: Vinod Mali | YEAR OF INC: 1987 | BSE CODE: 524669 | FV (Rs): 10 | DIV YIELD (%): 0.5 |
Read: HESTER BIOSCIENCES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare HESTER BIOSCIENCES With: AUROBINDO PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets defied weak Asian cues and traded on a positive note throughout the session.